kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS | OriGene Technologies Inc.
KRAS OriGene Technologies Inc. Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC Kras: structure and activation. (A) The Kras gene. Mutations in human Download Scientific Diagram
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



